CSL Limited (CSLLY) Investment Research Dashboard
About CSL Limited (CSLLY) stock analysis
Get live CSLLY stock price $21.08, comprehensive CSL Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time CSLLY stock data and investment insights.
Loading chart data...
CSL Limited (CSLLY) Overview
CSL Limited (CSLLY) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, CSLLY trades at $21.08 with a market capitalization of 81.63B . Over the past 52 weeks, CSLLY has traded between $16.01 and $44.85 , with the current price positioned at approximately 18% of this range . The stock currently trades at a pr...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 81.63B
- Current price: $21.08
- 52-week range: $16.01 - $44.85
- P/E ratio: 36.92
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
CSL Limited is a global biopharmaceutical enterprise dedicated to the research, development, production, marketing, and distribution of a wide array of biopharmaceutical and related healthcare products. The company boasts a significant international ...
Company Information
- CEO
- Gordon Naylor DipCompSc
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 32698
Contact Information
- Website
- https://www.csl.com
- Address
- 45 Poplar Road
- Country
- AU
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 36.9)
✓ Lower volatility stock (Beta: 0.08) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for CSL Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for CSL Limited
- ⚠Investors should consider how CSL Limited fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 36.9) requires strong growth to justify
Market Cap
81.63B
P/E Ratio (TTM)
36.92
Beta
0.08
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CSLLY with peer companies:
- Price
- $803.19-7.15% (1D)
- Market cap
- 49.95B
- Price
- $41.82-3.70% (1D)
- Market cap
- 68.83B
- Price
- $21.41+2.49% (1D)
- Market cap
- 70.47B
- Price
- $26.56+0.23% (1D)
- Market cap
- 106.39B
- Price
- $289.16+1.10% (1D)
- Market cap
- 17.75B
- Price
- $88.63+0.00% (1D)
- Market cap
- 107.50B
- Price
- $20.46+1.34% (1D)
- Market cap
- 22.85B
- Price
- $89.16+0.74% (1D)
- Market cap
- 107.40B
- Price
- $280.49-2.55% (1D)
- Market cap
- 53.39B
- Price
- $142.43+1.95% (1D)
- Market cap
- 54.23B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.